BSECentuple Global Ltd· Pharmaceuticals & BiotechnologyHighNegative
Announced Wed, 3 Dec, 2025 · 17:34 IST

Outcome of Board Meeting held on December 03, 2025

Kmp ResignedManagement Changes View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+2.0%Reaction day
₹105.32
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.5%+2.5% vs market
Pharmaceuticals peers, median of 156sector-0.2%+2.2% vs sector

On the reaction day the stock moved 2.5 pts more than Nifty Microcap 250 and 2.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+2.0-0.5+2.5-0.2+2.2
Next day
+4.0-1.7+5.7-0.5+4.6
2d
+6.1-4.0+10.1-2.6+8.7
3d
+8.2-2.1+10.3-1.9+10.1
4d
+6.1-2.7+8.8-2.0+8.1
5d
+3.9-2.3+6.2-1.2+5.1
1w
-0.2-1.5+1.4-0.7+0.5
15d
-6.3-1.8-4.5-1.3-5.0
1m
+25.5+0.1+25.3-0.3+25.8
2m
+4.4-3.3+7.8-5.6+10.1
3m
-43.5-11.2-32.3-10.2-33.3
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 156Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

At its December 3, 2025 board meeting, Checkpoint Trends Limited accepted the resignation of Mr. Pradeep Kumar (DIN: 00209355) as Whole-Time Director, effective the same day, citing personal reasons and pre-occupation. Mr. Shubham Chaudhary (DIN: 09298013) was re-designated from Whole-Time Director and CFO to Managing Director and CFO for a 3-year term, subject to shareholder approval. Mr. Anubhav Kumar Upadhyay (DIN: 09519842), a CA and CS with 15+ years of finance experience, was appointed as Whole-Time Director for 3 years, also pending shareholder approval. The proposed appointment of Mr. Gunjan Gangwal as Non-Executive Independent Director was deferred to the next board meeting.

Likely market impact

The leadership shuffle is largely a transition rather than a disruption — the existing CFO steps up to Managing Director while a new finance professional joins as WTD, maintaining continuity in financial oversight. Shareholders should watch for the upcoming EGM to approve these appointments, and the deferred independent director appointment is a pending governance item.